Sharma East India Hosp And Medical Research Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Sharma East India Hosp and Medical Research Ltd is ₹ 79.15 as of 23 Oct 15:30 . The P/E Ratio of Sharma East India Hosp and Medical Research Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 24 on March 2024 . This represents a CAGR of 9.65% over 4 years The Market Cap of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 985.7 crore on March 2024 . This represents a CAGR of 29.02% over 4 years The Revenue of Sharma East India Hosp and Medical Research Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Vimta Labs Ltd is ₹ 75.57 crore as of Jun '24 . The EBITDA of Sharma East India Hosp and Medical Research Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Vimta Labs Ltd is ₹ 25 crore as of Jun '24 . The Net Profit of Sharma East India Hosp and Medical Research Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Vimta Labs Ltd is ₹ 12.28 crore as of Jun '24 . The Dividend Payout of Sharma East India Hosp and Medical Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Sharma East India Hosp and Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989.
The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989. As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India.
It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Sharma East India Hosp and Medical Research Ltd or Vimta Labs Ltd?

Market cap of Sharma East India Hosp and Medical Research Ltd is 25 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd?

The stock performance of Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd?

As of October 25, 2026, the Sharma East India Hosp and Medical Research Ltd stock price is INR ₹79.15. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Sharma East India Hosp and Medical Research Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.